| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916000 | Nuclear Medicine and Biology | 2014 | 9 Pages |
Abstract
We describe the first 18F variant of a scFvanti-LIBS against activated platelets. This diagnostic agent could provide a powerful tool for the assessment of acute thrombosis and inflammation in patients in the future.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katie Ardipradja, Shinn Dee Yeoh, Karen Alt, Graeme O'Keefe, Angela Rigopoulos, David W. Howells, Andrew M. Scott, Karlheinz Peter, Uwe Ackerman, Christoph E. Hagemeyer,